½ÃÀ庸°í¼­
»óǰÄÚµå
1303564

¼¼°èÀÇ Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : Á¦Ç°, ÃÖÁ¾ »ç¿ëÀÚ ¹× Áö¿ªº° ºÐ¼®(2023-2030³â)

Global Intelligent Asthma Monitoring Devices Market Size study & Forecast, by Product (Wearable Asthma Monitoring Devices, Smart Inhalers, Nebulizers), By End-User (Hospitals, Homecare, Clinics) and Regional Analysis, 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº 2022³â ¾à 2¾ï 8,248¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, ¿¹Ãø ±â°£ÀÎ 2023³âºÎÅÍ 2030³â±îÁö 25.1% ÀÌ»óÀÇ °ÇÀüÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â´Â õ½Ä ȯÀÚµéÀÌ º¸´Ù È¿°úÀûÀ¸·Î ÁúȯÀ» °ü¸®ÇÒ ¼ö ÀÖµµ·Ï ÷´Ü ±â¼úÀ» Ȱ¿ëÇÑ Çõ½ÅÀûÀÎ µµ±¸ÀÔ´Ï´Ù. ÀÌ ÀåÄ¡´Â Æó ±â´É, Áõ»ó, ¾à¹° »ç¿ë, ȯ°æÀû ¿äÀÎ µî õ½Ä°ú °ü·ÃµÈ ´Ù¾çÇÑ ¸Å°³ º¯¼ö¸¦ ÃßÀûÇÏ°í ¸ð´ÏÅ͸µÇÏ¿© õ½Ä °ü¸®¸¦ À§ÇÑ ±ÍÁßÇÑ ÅëÂû·Â°ú Çǵå¹éÀ» Á¦°øÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº ³ëÀÎ Àα¸ Áõ°¡¿Í õ½Ä ȯÀÚ ±ÞÁõ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â´Â ÈíÀÔ ±â¼ú, ºóµµ, º¹¿ë·® µî »ç¿ëÀÚÀÇ ¾à¹° »ç¿ë ÇöȲÀ» ÃßÀûÇÏ´Â µ¥µµ µµ¿òÀÌ µË´Ï´Ù. À̸¦ ÅëÇØ ó¹æµÈ ¾à¹° ¿ä¹ýÀ» ÁؼöÇϰí õ½Ä Ä¡·áÁ¦ÀÇ °ú´Ù ¶Ç´Â °ú¼Ò »ç¿ëÀ» ¹æÁöÇÏ¿© Áõ»ó Á¶ÀýÀ» °³¼±Çϰí õ½Ä ¾ÇÈ­ À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. õ½Ä À¯º´·üÀº Áö³­ ¼ö½Ê³âµ¿¾È Á¡Â÷ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¼¼°èÀºÇà±×·ì¿¡ µû¸£¸é 2020³â ¼¼°è ³ëÀÎ Àα¸´Â 7¾ï 2,700¸¸ ¸íÀ̾úÀ¸¸ç, ÇâÈÄ 30³â°£ 3¹è Áõ°¡ÇØ 2050³â¿¡´Â 15¾ï ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ³ëÀÎ Àα¸¿Í ºñ¸¸ Àα¸´Â ¸¸¼º Áúȯ¿¡ °É¸®±â ½±´Ù. ¹Ì±¹ õ½Ä ¹× ¾Ë·¹¸£±â Àç´Ü¿¡ µû¸£¸é õ½ÄÀº 65¼¼ ÀÌ»ó ¼ºÀο¡¼­ ¸¹ÀÌ ¹ß»ýÇÕ´Ï´Ù. ¹Ì±¹ ³ëÀÎÀÇ ¾à 7.8%°¡ õ½ÄÀ» ¾Î°í ÀÖ½À´Ï´Ù. õ½Ä ¹ßº´·ü Áõ°¡µµ °ø°£ Áõ°¡¸¦ ÃËÁøÇÏ´Â ¶Ç ´Ù¸¥ Áß¿äÇÑ ¿ä¼Ò·Î, Statista¿¡ µû¸£¸é 2050³â Àεµ Àü¿ªÀÇ ³ëÀΠõ½Ä ȯÀÚ ¼ö´Â ¾à 2,540¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¶ÇÇÑ ¹Ì±¹¿¡¼­´Â 2020³â ÇöÀç õ½Ä ºñÀ²ÀÌ °¡Àå ³ôÀº ¿¬·É´ë´Â 15¼¼¿¡¼­ 34¼¼ »çÀÌ¿´À¸¸ç, ÃÑ 8.9%·Î º¸°íµÆ½À´Ï´Ù. ¶ÇÇÑ °í±Þ Ä¡·á ÇÁ·ÎÅäÄÝ¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÇ·áºñ ÁöÃâÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È ½ÃÀåÀÇ À¯¸®ÇÑ ¼ºÀå Àü¸ÁÀ» âÃâÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ±×·¯³ª Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±âÀÇ ³ôÀº ºñ¿ëÀº 2023-2030³âÀÇ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¼¼°èÀÇ Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â ÃֽŠÀÇ·á ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, ¿¬±¸ °³¹ß¿¡ ´ëÇÑ Á¤ºÎ Áö¿ø ¹× ÀÚ±Ý Áö¿øÀ¸·Î ÀÎÇØ 2022³â ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. ¹Ì±¹ ¾Ë·¹¸£±âõ½Ä¸é¿ªÇÐȸ(American College of Allergy, Asthma &Immunology)¿¡ µû¸£¸é 2020³â õ½ÄÀº ¼ºÀÎ 2,040¸¸ ¸í, ¼Ò¾Æ 610¸¸ ¸íÀ» Æ÷ÇÔÇØ ¹Ì±¹ Àα¸ÀÇ 8.3%¿¡ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ³ëÀÎ Àα¸ Áõ°¡¿Í õ½Ä À¯º´·ü Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È Å« ÆøÀ¸·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ Á¶»çÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³âµ¿¾È ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ ½ÃÀå ±Ô¸ð¸¦ ÆÄ¾ÇÇϰí ÇâÈÄ ¸î ³âµ¿¾È ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû/¾çÀû Ãø¸éÀ» ¸ðµÎ Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦¿Í °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷ÀÇ °æÀï ±¸µµ¿Í Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀåÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇԵ˴ϴÙ.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ÇöȲ
  • ¼¼°è ½ÃÀ塤ºÎ¹®º° ½ÃÀå Ã߻ꡤ¿¹Ãø, 2020-2030³â
    • Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : Áö¿ªº°, 2020-2030³â
    • Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : Á¦Ç°º°, 2020-2030³â
    • Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, 2020-2030³â
  • ÁÖ¿ä µ¿Çâ
  • Á¶»ç ¹æ¹ý
  • Á¶»çÀÇ ÀüÁ¦Á¶°Ç

Á¦2Àå ¼¼°èÀÇ Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â ½ÃÀå, Á¤ÀÇ¿Í ¹üÀ§

  • Á¶»ç ¸ñÀû
  • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
    • »ê¾÷ ¹ßÀü
    • Á¶»ç ¹üÀ§
  • Á¶»ç ´ë»ó³âµµ
  • ÅëÈ­ ȯ»êÀ²

Á¦3Àå ¼¼°èÀÇ Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ¿ªÇÐ

  • Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ¿µÇ⠺м®(2020-2030³â)
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
    • ½ÃÀå ±âȸ

Á¦4Àå ¼¼°èÀÇ Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : »ê¾÷ ºÐ¼®

  • Porter's Five Forces ¸ðµ¨
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ¹ÙÀ̾îÀÇ ±³¼··Â
    • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°è
  • Porter's Five ForcesÀÇ ¿µÇ⠺м®
  • PEST ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • COVID-19ÀÇ ¿µÇ⠺м®
  • ÆÄ±«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ °ßÇØ
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð ¹× Á¦¾È

Á¦5Àå ¼¼°èÀÇ Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : Á¦Ç°º°

  • ½ÃÀå ÇöȲ
  • ¼¼°èÀÇ Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : Á¦Ç°º°, ½ÇÀû, ÀáÀç ´É·Â ºÐ¼®
  • ¼¼°èÀÇ Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : Á¦Ç°º°, ÃßÁ¤¡¤¿¹Ãø2020-2030³â
  • Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • ¿þ¾î·¯ºí õ½Ä ¸ð´ÏÅ͸µ ±â±â
    • ½º¸¶Æ® ÈíÀÔ±â
    • ³×ºæ¶óÀÌÀú

Á¦6Àå ¼¼°èÀÇ Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ½ÃÀå ÇöȲ
  • ¼¼°èÀÇ Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, ½ÇÀû-°¡´É¼º ºÐ¼®
  • ¼¼°èÀÇ Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, ÃßÁ¤¡¤¿¹Ãø 2020-2030³â
  • Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • º´¿ø
    • ÀçÅÃÄ¡·á
    • Áø·á¼Ò

Á¦7Àå ¼¼°èÀÇ Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : Áö¿ªº° ºÐ¼®

  • ÁÖ¿ä ±¹°¡
  • ÁÖ¿ä ½ÅÈï ±¹°¡
  • Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â ½ÃÀå, Áö¿ªº° ½ÃÀå ÇöȲ
  • ºÏ¹Ì
    • ¹Ì±¹
      • Á¦Ç° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
      • ÃÖÁ¾»ç¿ëÀÚ ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
    • ij³ª´Ù
  • À¯·´ÀÇ Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ÇöȲ
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ÇöȲ
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ÇöȲ
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦8Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • AstraZeneca PLC
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍ ÀÔ¼ö°¡ °¡´ÉÇÑ °æ¿ì)
      • Á¦Ç° °³¿ä
      • ÃÖ±Ù µ¿Çâ
    • Cohero Health Inc
    • Glaxosmithkline PLC
    • Omron Corporation
    • Koninklijke Philips N.V
    • Reciprocal Labs Corporation
    • Teva Pharmaceuticals Industries Ltd
    • Vectura Group Plc
    • Volansys Technologies Pvt Ltd
    • Nihon Kohden Corporation

Á¦9Àå Á¶»ç °úÁ¤

  • Á¶»ç °úÁ¤
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • °ËÁõ
    • ÃâÆÇ
  • Á¶»ç ¼Ó¼º
  • Á¶»çÀÇ ÀüÁ¦Á¶°Ç
LSH 23.08.04

Global Intelligent Asthma Monitoring Devices Market is valued at approximately USD 282.48 million in 2022 and is anticipated to grow with a healthy growth rate of more than 25.1% over the forecast period 2023-2030. Intelligent asthma monitoring devices are innovative tools that use advanced technology to help individuals with asthma manage their conditions more effectively. These devices are designed to track and monitor various parameters related to asthma, such as lung function, symptoms, medication usage, and environmental triggers, to provide valuable insights and feedback for better asthma management. The Intelligent Asthma Monitoring Devices market is expanding because of factors such as growing geriatric population and surge in incidence of asthma cases. Intelligent asthma monitoring devices can also help users track their medication usage, including inhaler technique, frequency, and dosage. This can help individuals adhere to their prescribed medication regimen and avoid overuse or underuse of asthma medications, leading to better symptom control and reduced risk of asthma exacerbations. Its prevalence has progressively increased during the last few decades.

According to the World Bank Group, In 2020, the world's elderly population was 727 million, and it is expected to triple over the next three decades, reaching 1.5 billion in 2050. Furthermore, geriatric and obese populations are predisposed to chronic diseases. As per the Asthma and Allergy Foundation of America, asthma is common in adults aged 65 and older. Around 7.8% of older adults in the United States have asthma. Another important component driving space increase is rising incidence of asthma cases. As per Statista, the number of cases of asthma in senior citizens across India in 2050 was forecasted to be about 25.4 million. In addition, in 2020, in the United States, the highest percentage of current asthma was reported for the age group ranging from 15 to 34 years, with a total value of 8.9%. Also, increased focus toward advanced treatment protocols and rising healthcare expenditure. would create a lucrative growth prospectus for the market over the forecast period. However, the high cost of Intelligent Asthma Monitoring Devices stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Intelligent Asthma Monitoring Devices Market study include: Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rising investment in modern healthcare technologies and government support and funding for research & development. According to the American College of Allergy, Asthma & Immunology, in 2020, Asthma affects 8.3% of the American population, including 20.4 million adults and 6.1 million children. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric populations and increasing prevalence of asthma in the market space.

Major market players included in this report are:

  • AstraZeneca PLC
  • Cohero Health Inc
  • Glaxosmithkline PLC
  • Omron Corporation
  • Koninklijke Philips N.V
  • Reciprocal Labs Corporation
  • Teva Pharmaceuticals Industries Ltd
  • Vectura Group Plc
  • Volansys Technologies Pvt Ltd
  • Nihon Kohden Corporation

Recent Developments in the Market:

  • In April 2023 OMRON Corporation launched the NX-series NX502-1x00 CPU Units automation controllers with advanced information control and safety control, and the NX-EIP201 EtherNet/IP. The NX502 CPU Units and NX-EIP201 EtherNet/IP Units utilize the capabilities of OMRON's own advanced information processing, communications technologies, and large-capacity memory to achieve real-time analysis and process modularization which helps to reduce resource disposal losses at manufacturing locations and shorten lead times while changing lines.

Global Intelligent Asthma Monitoring Devices Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Product, End-User, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product

  • Wearable Asthma Monitoring Devices
  • Smart Inhalers
  • Nebulizers

By End-User

  • Hospitals
  • Homecare
  • Clinics

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
    • 1.2.1. Intelligent Asthma Monitoring Devices Market, by Region, 2020-2030 (USD Million)
    • 1.2.2. Intelligent Asthma Monitoring Devices Market, by Product, 2020-2030 (USD Million)
    • 1.2.3. Intelligent Asthma Monitoring Devices Market, by End-User, 2020-2030 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Intelligent Asthma Monitoring Devices Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Intelligent Asthma Monitoring Devices Market Dynamics

  • 3.1. Intelligent Asthma Monitoring Devices Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing Geriatric Population
      • 3.1.1.2. Surge in incidence of asthma cases
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Intelligent Asthma Monitoring Devices
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increased focus toward advanced treatment protocols
      • 3.1.3.2. Rising healthcare expenditure

Chapter 4. Global Intelligent Asthma Monitoring Devices Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Intelligent Asthma Monitoring Devices Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Intelligent Asthma Monitoring Devices Market by Product, Performance - Potential Analysis
  • 5.3. Global Intelligent Asthma Monitoring Devices Market Estimates & Forecasts by Product 2020-2030 (USD Million)
  • 5.4. Intelligent Asthma Monitoring Devices Market, Sub Segment Analysis
    • 5.4.1. Wearable Asthma Monitoring Devices
    • 5.4.2. Smart Inhalers
    • 5.4.3. Nebulizers

Chapter 6. Global Intelligent Asthma Monitoring Devices Market, by End-User

  • 6.1. Market Snapshot
  • 6.2. Global Intelligent Asthma Monitoring Devices Market by End-User, Performance - Potential Analysis
  • 6.3. Global Intelligent Asthma Monitoring Devices Market Estimates & Forecasts by End-User 2020-2030 (USD Million)
  • 6.4. Intelligent Asthma Monitoring Devices Market, Sub Segment Analysis
    • 6.4.1. Hospitals
    • 6.4.2. Homecare
    • 6.4.3. Clinics

Chapter 7. Global Intelligent Asthma Monitoring Devices Market, Regional Analysis

  • 7.1. Top Leading Countries
  • 7.2. Top Emerging Countries
  • 7.3. Intelligent Asthma Monitoring Devices Market, Regional Market Snapshot
  • 7.4. North America Intelligent Asthma Monitoring Devices Market
    • 7.4.1. U.S. Intelligent Asthma Monitoring Devices Market
      • 7.4.1.1. Product breakdown estimates & forecasts, 2020-2030
      • 7.4.1.2. End-User breakdown estimates & forecasts, 2020-2030
    • 7.4.2. Canada Intelligent Asthma Monitoring Devices Market
  • 7.5. Europe Intelligent Asthma Monitoring Devices Market Snapshot
    • 7.5.1. U.K. Intelligent Asthma Monitoring Devices Market
    • 7.5.2. Germany Intelligent Asthma Monitoring Devices Market
    • 7.5.3. France Intelligent Asthma Monitoring Devices Market
    • 7.5.4. Spain Intelligent Asthma Monitoring Devices Market
    • 7.5.5. Italy Intelligent Asthma Monitoring Devices Market
    • 7.5.6. Rest of Europe Intelligent Asthma Monitoring Devices Market
  • 7.6. Asia-Pacific Intelligent Asthma Monitoring Devices Market Snapshot
    • 7.6.1. China Intelligent Asthma Monitoring Devices Market
    • 7.6.2. India Intelligent Asthma Monitoring Devices Market
    • 7.6.3. Japan Intelligent Asthma Monitoring Devices Market
    • 7.6.4. Australia Intelligent Asthma Monitoring Devices Market
    • 7.6.5. South Korea Intelligent Asthma Monitoring Devices Market
    • 7.6.6. Rest of Asia Pacific Intelligent Asthma Monitoring Devices Market
  • 7.7. Latin America Intelligent Asthma Monitoring Devices Market Snapshot
    • 7.7.1. Brazil Intelligent Asthma Monitoring Devices Market
    • 7.7.2. Mexico Intelligent Asthma Monitoring Devices Market
  • 7.8. Middle East & Africa Intelligent Asthma Monitoring Devices Market
    • 7.8.1. Saudi Arabia Intelligent Asthma Monitoring Devices Market
    • 7.8.2. South Africa Intelligent Asthma Monitoring Devices Market
    • 7.8.3. Rest of Middle East & Africa Intelligent Asthma Monitoring Devices Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Company 1
    • 8.1.2. Company 2
    • 8.1.3. Company 3
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. AstraZeneca PLC
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Recent Developments
    • 8.3.2. Cohero Health Inc
    • 8.3.3. Glaxosmithkline PLC
    • 8.3.4. Omron Corporation
    • 8.3.5. Koninklijke Philips N.V
    • 8.3.6. Reciprocal Labs Corporation
    • 8.3.7. Teva Pharmaceuticals Industries Ltd
    • 8.3.8. Vectura Group Plc
    • 8.3.9. Volansys Technologies Pvt Ltd
    • 8.3.10. Nihon Kohden Corporation

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦